Celltrion presents data for COVID-19 monoclonal antibody treatment candidate CT-P59
It demonstrated promising safety, tolerability, antiviral effect, and efficacy profile of CT-P59 in patients with mild symptoms of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Jubilant Pharma and Aavis Pharma launch Hydroxychloroquine Sulfate tablets in US
The product will be distributed by Jubilant Cadista, a unit of Jubilant Pharma
Skills and talents deficit poses biggest challenge to digital transformation in pharma
The success of digital transformation will heavily depend on employees being on board and adapting as digital transformation…
Reassess your ‘alternatives’
Sanjaya Mariwala, Executive Chairman and Managing Director of OmniActive Health Technologies opines that it is time to give…
Creating Superior Activated Carbon That Solves Common Challenges Faced By Active Packaging
Cilicant offers a superior product made by using coconut shells which is very pure and efficient, tends to be denser with a…
Disappointing SOLIDARITY results for remdesivir likely due to trial differences and not the drug:…
The SOLIDARITY trial did show that large-scale international trials are possible during a pandemic with the possibility of drawing…
Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Thu, 5 November, 2020 | 3:00 PM - 4:00 PM IST - 60 Min
Dr Harsh Vardhan gives away Gandhian Young Technological Awards in two categories
Fourteen awards and eleven appreciations under SITARE-GYTI, seven awards and 16 appreciations under SRISTI-GYTI were presented
Covaxin may get launched in February 2021: ICMR scientist
The company had earlier hoped to launch it only in the second quarter of next year.
DoP forms expert committee to identify investment opportunities, bottlenecks in pharma industry
The committee needs to submit an action plan by November 6